3-(2,2'-bithiophenyl-5-carbonyl)-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylic acid ethyl ester | 629666-32-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 双噻吩和低聚噻吩
• 英文名称: 3-(2,2'-bithiophenyl-5-carbonyl)-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylic acid ethyl ester
• 英文别名: ethyl 3-(5-thiophen-2-ylthiophene-2-carbonyl)-2,6-dihydro-1H-azepino[4,5-b]indole-5-carboxylate
• CAS: 629666-32-6
• 化学式: C₂₄H₂₀N₂O₃S₂
• 分子量: 448.566
• InChiKey: NHHPHFQFJKBWIA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  31
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  119
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• Azepinoindole derivatives as pharmaceutical agents
  申请人：Busch Brett

  公开号：US20050054634A1

  公开（公告）日：2005-03-10

  Compounds, compositions and methods for modulating the activity of receptors are provided. In particular, compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.

  提供了用于调节受体活性的化合物、组合物和方法。具体来说，提供了用于调节受体活性以及用于治疗、预防或改善与受体活性直接或间接相关的一种或多种疾病或紊乱症状的化合物和组合物。
• Azepinoindole and pyridoindole derivatives as pharmaceutical agents
  申请人：X-Ceptor Therapeutics Inc.

  公开号：US20040023947A1

  公开（公告）日：2004-02-05

  Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.

  提供了调节受体活性的化合物、组合物和方法。特别提供了用于调节受体活性和治疗、预防或改善与受体活性直接或间接相关的一种或多种疾病或障碍症状的化合物和组合物。
• Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents
  申请人：Martin Richard

  公开号：US20090326218A1

  公开（公告）日：2009-12-31

  Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.

  本发明提供了用于调节受体活性的化合物、组合物和方法。特别提供了用于调节受体活性的化合物和组合物，以及用于治疗、预防或缓解与受体活性直接或间接相关的一种或多种疾病或障碍的症状的方法。
• AZEPINOINDOLE AND PYRIDOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS
  申请人：X-Ceptor Therapeutics, Inc.

  公开号：EP1532153B1

  公开（公告）日：2012-02-29
• AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS
  申请人：X-Ceptor Therapeutics, Inc.

  公开号：EP1692136A2

  公开（公告）日：2006-08-23